Drug Database
Back to search

United States· US:49643-104_36ad1e17-751d-e226-e063-6394a90ab328

Botrytis

A medicinal product containing botrytis cinerea, registered in United States by Allermed Laboratories, Inc..

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedBotrytisATC—REGISTER NO.US:49643-104_36ad1e17…PACKS LISTED8CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about botrytis cinereaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
BOTRYTIS CINEREA
Manufacturer
Allermed Laboratories, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 8

  • ndc11
    4964310405
    5 mL in 1 VIAL, MULTI-DOSE (49643-104-05)
  • ndc11
    4964310410
    10 mL in 1 VIAL, MULTI-DOSE (49643-104-10)
  • ndc11
    4964310430
    30 mL in 1 VIAL, MULTI-DOSE (49643-104-30)
  • ndc11
    4964310450
    50 mL in 1 VIAL, MULTI-DOSE (49643-104-50)
  • ndc11
    49643-104-10
  • ndc11
    49643-104-30
  • ndc11
    49643-104-05
  • ndc11
    49643-104-50

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Botrytis cinerea in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All botrytis cinerea products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Prick-Testlösung Botrytis Cinerea, Provokations-Testlösung Botrytis Cinerea
  • Hungary · Alyostal Prick Penészgombák Allergén Kivonatot Tartalmazó Oldatok, Allergiás Betegségek Diagnosztizálásában Használatos Prick Tesztek Végzésére, Staloral

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3b1ed178-28fe-428c-a937-536a9935d5f3
GET /v1/drugs/3b1ed178-28fe-428c-a937-536a9935d5f3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "CUTANEOUS; INTRADERMAL; SUBCUTANEOUS",
  "source": "ndc",
  "strength": ".1",
  "substance": "BOTRYTIS CINEREA",
  "productndc": "49643-104",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "g/mL",
  "application_number": "BLA102211",
  "marketing_category": "BLA"
}
API referenceMCP serverPlans

See everything about botrytis cinerea.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console